Derivatives of 4-(imidazol-5-YL)-2-(4-sulfoanilino) pyrimidine with CDK inhibitory activity
A Standard patent application filed on 06 March 2003 credited to Newcombe, Nicholas, John ; Thomas, Andrew, Peter

Details

Application number :

2003214394  

Application type :

Standard  

Application status :

LAPSED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Derivatives of 4-(imidazol-5-YL)-2-(4-sulfoanilino) pyrimidine with CDK inhibitory activity  

Inventor :

Newcombe, Nicholas, John ; Thomas, Andrew, Peter  

Agent name :

Davies Collison Cave  

Address for service :

1 Nicholson Street Melbourne VIC 3000 Australia  

Filing date :

06 March 2003  

Associated companies :

 

Applicant name :

AstraZeneca AB  

Applicant address :

Sodertalje S-151 85 Sweden  

Old name :

 

Original Source :

Go  

Same Inventor

• 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
• Pyrimidine compounds
• 4- imidazolyl substuited pyrimidine derivatives with cdk...
• Pyrimidine compounds